PHILADELPHIA (Jan. 17, 2022) A new study by researchers at The Wistar Institute , an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, has identified a new potential pathway for developing therapeutics that target Epstein-Barr virus ( EBV ).